Related Experiment Video
Updated: Jun 15, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic
Maha Mohamed Eissa1, Sonia Rifaat Ahmed Allam1, Cherine Adel Ismail2
1Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Al-Moassat Medical Campus, Alexandria, Egypt.
Abstract:
Cancer is one of the most dreaded diseases worldwide. Conventional treatments such as surgery, chemotherapy, and radiotherapy have limitations and adverse effects. Cancer immunotherapy and targeted therapies offer new treatment options. Parasite-based cancer therapy shows promise in fighting tumors. Some parasites have anti-cancer properties through multi-mechanistic strategies, with the molecular mimicry theory as a leading explanation for parasites' anti-cancer effects. This study aimed to explore the existence of shared antigenic proteins between parasites (Trichinella spiralis, Schistosoma mansoni, and Toxoplasma gondii) and cancer cell lines (MCF-7 human breast cancer and A549 human lung cancer). Polyclonal antisera against T. spiralis, S. mansoni, and T. gondii parasites were generated in rabbits. Antibody reactivity with extracts of MCF-7 and A549 cancer cells was detected using SDS-PAGE and immunoblotting. Results documented the molecular mimicry between parasites and cancers as it revealed cross-reactive bands when using T. spiralis antibodies against MCF-7 and A549 cancer cell extracts at approximate molecular weights of 70 and 35 kDa, and with S. mansoni antibodies at an approximate molecular weight of 80 kDa. Toxoplasma gondii antibodies neither reacted with MCF-7 human breast cancer nor A549 human lung cancer cell extracts. Results of this study could establish a foundation for subsequent investigation among a broad range of parasites for molecular mimicry with cancers. Identification, molecular characterization, and investigation of the anti-neoplastic activity of these cross-reactive antigens could shed light on new pathways for the potential development of a novel class of innovative cancer vaccine candidates and therapeutic antibodies of parasitic origin for cancer immunotherapy and targeted therapy.
Insights
This study explored molecular mimicry between parasites and cancer cells, finding shared antigens between Trichinella spiralis and Schistosoma mansoni with breast and lung cancer cells. This discovery could lead to new parasite-derived cancer immunotherapies.
Area of Science:
- Immunology
- Parasitology
- Oncology
Background:
- Conventional cancer treatments have limitations and side effects.
- Cancer immunotherapy and targeted therapies are emerging as promising alternatives.
- Parasite-based cancer therapy, particularly leveraging molecular mimicry, shows potential for novel anti-cancer strategies.
Purpose of the Study:
- To investigate shared antigenic proteins between specific parasites (Trichinella spiralis, Schistosoma mansoni, Toxoplasma gondii) and human cancer cell lines (MCF-7, A549).
- To explore the molecular mimicry theory as a basis for parasite-mediated anti-cancer effects.
Main Methods:
- Generation of polyclonal antisera against T. spiralis, S. mansoni, and T. gondii in rabbits.
- Detection of antibody reactivity with cancer cell extracts using SDS-PAGE and immunoblotting.
- Analysis of cross-reactivity to identify shared antigens between parasites and cancer cells.
Main Results:
- Cross-reactive bands were observed between T. spiralis antibodies and both MCF-7 and A549 cancer cell extracts (approx. 70 and 35 kDa).
- Cross-reactivity was also found between S. mansoni antibodies and cancer cell extracts (approx. 80 kDa).
- T. gondii antibodies did not show reactivity with the tested cancer cell lines.
Conclusions:
- The study provides evidence for molecular mimicry between T. spiralis and S. mansoni parasites and human breast and lung cancer cells.
- These findings lay the groundwork for further research into parasite-cancer antigen interactions.
- Identification of these cross-reactive antigens could pave the way for developing novel cancer vaccines and therapeutic antibodies derived from parasites.
More Related Videos
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...